Bahramian Ayla, Pakdel Farzaneh, Pourzare Mehrbani Solmaz, Golchin Ehsan, Maljaei Ensiyeh, Hosseinpour Sarmadi Maryam, Deljavanghodrati Tara, Katebi Katayoun
Department of Oral and Maxillofacial Medicine, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
Toxoplasmosis Research Center, Mazandaran University of Medical Science, Sari, Iran.
J Adv Periodontol Implant Dent. 2025 Jan 20;17(1):26-30. doi: 10.34172/japid.2025.004. eCollection 2025 Mar.
Desquamative gingivitis is an immunological chronic disease that is considered precancerous and has the potential to develop into squamous cell carcinoma. Carcinoembryonic antigen (CEA), a common tumor marker, increases in many cancers. The present study compared salivary CEA levels in desquamative gingivitis before and after topical corticosteroid therapy.
This case‒control study was conducted in the Department of Oral and Maxillofacial Medicine, Tabriz Faculty of Dentistry. Twenty patients with desquamative gingivitis in oral lichen planus (OLP) background were selected as the case group, with 20 healthy individuals as the control group. Desquamative gingivitis lesions were confirmed with biopsies. Salivary samples were obtained from both groups. Second, salivary samples were collected from the case group after a course of topical corticosteroid therapy. Salivary CEA levels were measured by a monobind kit using the ELISA method. Independent and paired t-tests were used to analyze the data in SPSS 17. <0.05 was considered statistically significant.
Before treatment, CEA levels were significantly higher in the case group (174.06±95.55) than in the control group (55.66±41.26 ng/mL) (<0.001). Salivary CEA levels in the case group decreased significantly after the treatment (96.77±66.25 ng/mL) compared to before treatment (174.06±95.55 ng/mL) (<0.001).
This study demonstrated that CEA levels significantly decreased in patients with desquamative gingivitis associated with oral lichenoid reaction after receiving topical corticosteroid therapy.
剥脱性龈炎是一种免疫性慢性疾病,被认为是癌前病变,有发展为鳞状细胞癌的可能。癌胚抗原(CEA)是一种常见的肿瘤标志物,在许多癌症中都会升高。本研究比较了局部应用糖皮质激素治疗前后剥脱性龈炎患者唾液中CEA的水平。
本病例对照研究在大不里士牙科系口腔颌面医学科进行。选取20例口腔扁平苔藓(OLP)背景下的剥脱性龈炎患者作为病例组,20名健康个体作为对照组。通过活检确诊剥脱性龈炎病变。采集两组的唾液样本。其次,在病例组接受一个疗程的局部糖皮质激素治疗后采集唾液样本。使用ELISA方法通过单克隆抗体试剂盒测量唾液CEA水平。在SPSS 17中使用独立样本t检验和配对t检验分析数据。P<0.05被认为具有统计学意义。
治疗前,病例组CEA水平(174.06±95.55)显著高于对照组(55.66±41.26 ng/mL)(P<0.001)。病例组治疗后唾液CEA水平(96.77±66.25 ng/mL)较治疗前(174.06±95.55 ng/mL)显著降低(P<0.001)。
本研究表明,接受局部糖皮质激素治疗后,与口腔苔藓样反应相关的剥脱性龈炎患者的CEA水平显著降低。